Professor Emeritus of Psychiatry
Research Professor Emeritus
Michigan Neuroscience Institute
[email protected]
Available to mentor
John F Greden
Professor Emeritus/a
-
Center MemberPrecision Health Initiative
-
Center MemberEisenberg Family Depression Center
-
Singh B, Parikh SV, Voort JLV, Pazdernik VK, Achtyes ED, Goes FS, Yocum AK, Nykamp L, Becerra A, Smart L, Greden JF, Bobo WV, Frye MA, Burdick KE, Ryan KA. Psychiatry Res, 2024 May; 335: 115829Journal ArticleChange in neurocognitive functioning in patients with treatment-resistant depression with serial intravenous ketamine infusions: The Bio-K multicenter trial.
DOI:10.1016/j.psychres.2024.115829 PMID: 38479192 -
Parikh SV, Vande Voort JL, Yocum AK, Achtyes E, Goes FS, Nykamp L, Singh B, Lopez-Vives D, Sera CE, Maixner D, Tarnal V, Severe J, Bartek S, Tye SJ, Rico J, Stoppel CJ, Becerra A, Smart L, Miller CR, Frye MA, Greden JF, Bobo WV. J Affect Disord, 2024 Mar 1; 348: 143 - 151.Journal ArticleClinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression.
DOI:10.1016/j.jad.2023.12.033 PMID: 38142892 -
Lapidos A, Lopez-Vives D, Sera CE, Ahearn E, Vest E, Senic I, Vande Voort JL, Frye M, Goes FS, Achtyes E, Greden J, Parikh SV. Journal of Affective Disorders, 2023 Feb 15; 323: 534 - 539.Journal ArticlePatients' recovery and non-recovery narratives after intravenous ketamine for treatment-resistant depression
DOI:10.1016/j.jad.2022.11.090 -
Lapidos A, Lopez-Vives D, Sera CE, Ahearn E, Vest E, Senic I, Vande Voort JL, Frye M, Goes FS, Achtyes E, Greden J, Parikh SV. J Affect Disord, 2023 Feb 15; 323: 534 - 539.Journal ArticlePatients' recovery and non-recovery narratives after intravenous ketamine for treatment-resistant depression.
DOI:10.1016/j.jad.2022.11.090 PMID: 36481228 -
Lapidos A, Lopez-Vives D, Sera CE, Ahearn E, Vest E, Senic I, Vande Voort JL, Frye M, Goes FS, Achtyes E, Greden J, Parikh SV. Journal of Affective Disorders, 2023 Feb; 323: 534 - 539.Journal ArticlePatients' recovery and non-recovery narratives after intravenous ketamine for treatment-resistant depression
DOI:10.1016/j.jad.2022.11.090 -
Lapidos A, Lopez-Vives D, Sera CE, Ahearn E, Vest E, Senic I, Vande Voort JL, Frye M, Goes FS, Achtyes E, Greden J, Parikh SV. Journal of affective disorders, 2023 Feb; 323: 534 - 539.Journal ArticlePatients' recovery and non-recovery narratives after intravenous ketamine for treatment-resistant depression.
DOI:10.1016/j.jad.2022.11.090 -
Taubman DS, Heininger W, Salazar S, Salazar L, Riba MB, Greden JF, Parikh SV. Acad Psychiatry, 2022 Jun; 46 (3): 359 - 363.Journal ArticleDepression on College Campuses Conference: Addressing an Evolving Crisis.
DOI:10.1007/s40596-021-01575-z PMID: 34855155 -
Tandon R, Greden JF. Schizophr Res, 2022 Apr; 242: 42 - 44.Journal ArticleReconstructing schizophrenia: Lessons from major mood disorders.
DOI:10.1016/j.schres.2022.02.001 PMID: 35168835